Benjamin Edwards Inc Baxter International Inc Transaction History

Benjamin Edwards Inc

$503 Million
Q1 2024

A detailed history of Benjamin Edwards Inc transactions in Baxter International Inc stock. As of the latest transaction made, Benjamin Edwards Inc holds 204 shares of BAX stock, worth $6,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares

204

Previous 204 -0.0%

Holding current value

$6,938

Previous $8,000 12.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$31.71 - $38.95 $24,892 - $30,575	-785 Reduced 79.37%	204 $8,000
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $2,761 - $3,647	-74 Reduced 6.96%	989 $37,000
Q2 2023 Aug 15, 2023	SELL	$39.98 - $47.68 $11,794 - $14,065	-295 Reduced 21.72%	1,063 $48,000
Q1 2023 Apr 27, 2023	BUY	$37.58 - $52.57 $32,469 - $45,420	864 Added 174.9%	1,358 $55,000
Q4 2022 Feb 07, 2023	SELL	$49.7 - $57.71 $37,921 - $44,032	-763 Reduced 60.7%	494 $25,000

Q3 2022 Oct 28, 2022	SELL	$53.86 - $66.8 $217,809 - $270,139	-4,044 Reduced 76.29%	1,257 $68,000
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $7,340 - $9,200	-115 Reduced 2.12%	5,301 $340,000
Q1 2022 May 04, 2022	BUY	$76.85 - $89.45 $230,242 - $267,992	2,996 Added 123.8%	5,416 $420,000
Q4 2021 Feb 07, 2022	BUY	$74.57 - $87.19 $175,164 - $204,809	2,349 Added 3308.45%	2,420 $208,000
Q2 2021 Aug 11, 2021	BUY	$80.5 - $88.01 $80 - $88	1 Added 1.43%	71 $6,000
Q1 2020 May 07, 2020	BUY	$71.57 - $93.3 $71 - $93	1 Added 1.45%	70 $6,000
Q2 2019 Aug 08, 2019	BUY	$73.44 - $82.41 $5,067 - $5,686	69 New	69 $6,000

Others Institutions Holding BAX

# of Institutions

1,025

Shares Held

442M

Call Options Held

4.22M

Put Options Held

2.52M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Baxter International Inc Transaction History